Abstract
Infection with SARS-CoV-2 causes COVID-19, leading to significant lung tissue damage. The open reading frame 8 (ORF8) protein is a unique accessory protein with poorly understood cellular functions. This study examined the cellular distribution of ORF8 and its role in lung epithelial cell proliferation and antiviral immunity. Ectopically expressed ORF8 was found to form aggregates in the cytosol and nucleus, driven by an intrinsic aggregation characteristic in its N-terminal residues 1-18. While ORF8 expression did not affect cell proliferation or cycle progression, it significantly suppressed the basal expression of antiviral molecules (DHX58, ZBP1, MX1, MX2) and attenuated the induction of these molecules by IFNγ. These findings suggest ORF8 facilitates viral escape from the host innate immune response.
Introduction
SARS-CoV-2 infection is characterized by severe lung injury, yet the specific mechanisms by which viral proteins manipulate host cell biology remain a subject of intense study. While structural proteins like Spike (S) and Nucleocapsid (N) are well-characterized, "accessory proteins"—which are not strictly required for viral replication but often modulate host immunity—are less understood. ORF8 is one such protein, notable for its high rate of evolution and unique sequence. This research investigates where ORF8 localizes within human lung cells and how it might interfere with the interferon (IFN) response, the body's primary defense against viral infection.
Methods
The study utilized human lung epithelial cells (A549) and HEK293 cells as models. To track the protein, researchers engineered expression plasmids containing the ORF8 sequence (derived from RefSeq MN908947) fused to Enhanced Green Fluorescent Protein (eGFP).
Protein localization was visualized using high-resolution "Thunder" microscopy and immunofluorescent staining. The aggregation potential of ORF8 was predicted in silico using the PASTA 2.0 algorithm. Functional impacts on the cell cycle were assessed via flow cytometry, and the expression of Interferon-Stimulated Genes (ISGs) was quantified using RT-qPCR following treatment with IFNβ or IFNγ.
Results
ORF8 Forms Intracellular Aggregates
Bioinformatic analysis identified a highly "sticky" region at the N-terminus (residues 1-18) of ORF8, suggesting a natural propensity to clump. Experimental results confirmed this: while control eGFP was distributed evenly throughout the cell, ORF8-eGFP formed distinct, dense aggregates in both the cytoplasm and the nucleus.
Selective Suppression of Antiviral Immunity
Interestingly, the presence of these ORF8 aggregates did not impair basic cellular functions like growth or division. Instead, ORF8 acted as a selective immune suppressor. It lowered the baseline levels of several key antiviral sensors, including DHX58 and ZBP1, and effectors like MX1 and MX2.
Crucially, ORF8 specifically hindered the cell's ability to respond to Type II interferon (IFNγ). While the response to Type I interferon (IFNβ) remained largely intact, the "boost" in antiviral gene expression normally triggered by IFNγ was significantly blunted in cells expressing ORF8.
Discussion
The ability of ORF8 to form stable aggregates without killing the host cell suggests a sophisticated strategy for long-term immune evasion. By selectively blocking the IFNγ pathway, SARS-CoV-2 can bypass a critical arm of the innate immune system.
The stability of these aggregates raises questions about their persistence. The authors hypothesize that if ORF8 aggregates remain in lung cells after the virus has been cleared, they might contribute to the prolonged inflammatory or respiratory issues seen in "Long-COVID" patients. Future research is needed to identify the specific host proteins that ORF8 interacts with to achieve this targeted suppression.
Summary updated